# OnCo record cytokine-therapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/cytokine-therapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "cytokine-therapy" ;
  schema:name "Cytokines & engineered cytokines"@en ;
  schema:description "Cytokine therapy gives immune-signalling proteins as drugs. High-dose interleukin-2 was the first immunotherapy to cure some melanomas, at great toxicity."@en ;
  schema:url <https://onco.cc/technologies/cytokine-therapy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cytokine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q212354> ;
  schema:citation <https://en.wikipedia.org/wiki/Cytokine> ;
  onco:status "approved" ;
  onco:related <https://onco.cc/technologies/immunocytokines/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/rcc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/lenograstim/>, <https://onco.cc/drugs/peginterferon-alfa-2b/>, <https://onco.cc/drugs/oprelvekin/> ;
  onco:companies <https://onco.cc/companies/amunix-pharmaceuticals/>, <https://onco.cc/companies/asher-bio/>, <https://onco.cc/companies/geneos-therapeutics/>, <https://onco.cc/companies/granza-bio/>, <https://onco.cc/companies/strand-therapeutics/>, <https://onco.cc/companies/synsorybio/>, <https://onco.cc/companies/werewolf-therapeutics/>, <https://onco.cc/companies/xilio-therapeutics/> .